Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.

Also called NCT02334007

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 1/2
Enrolled
  • 102 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02334007
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02334007. Randomized; quadruple masking; primary purpose prevention. Start 2015-09 (registry gives no type); primary completion 2018-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
Condition
Venous Thromboembolism
Condition
Lung Neoplasms
Intervention (Drug)
LMWH: Dalteparin
Intervention (Other)
Placebo
Lead sponsor
McMaster University (class: other)

Record details

Record id
cardio:ct-nct02334007
Content hash
dd70284344aa6560b27f6cfe7f8c24485cb337a43d621bc6b66d90d28d6f117e